Tag: CDRI
Indian scientists spot ‘Troublemaker’ immune cells driving inflammation
The scientists at CSIR-CDRI identify special type of immune cells associated with inflammation
CTDDR-2022: CDRI organizes 9th Maha Kumbh for drug research
The eminent speakers ignited the spark of scientific temperament in the participants of CTDDR-2025 with their vibrant talks filled with the latest information.
CSIR-CDRI Lucknow and Zydus to develop best-in-class drug for CKD induced...
Under this agreement, CDRI and Zydus will jointly undertake preclinical research. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets
CSIR-CDRI celebrates its 73rd Annual Day acknowledging significant achievements
The Institute paid its tributes to the former Directors of CSIR-CDRI Padmashri Dr. Nitya Anand and Dr. VP Kamboj who recently passed away
Cipla partners with CSIR-CDRI to develop advanced ophthalmic antifungal treatment
The collaboration aims to leverage the combined expertise and resources of both organizations to develop a safe and efficacious drug for fungal keratitis
CSIR-CDRI & TETC India will organize symposium on career development in...
The institute is also organizing Silver Jubilee 25th INDO-US Flow Cytometry Workshop on “Flow Cytometry and its Advanced Applications in Biological Sciences"
CSIR-CDRI initiates a new oration series on InnoHealth to foster innovation...
The event focused on unravelling the multifaceted role of AI in accelerating healthcare innovations, a topic of critical relevance in the contemporary medical landscape
CSIR’s EPIC Hackathon-2024: Sustainable solutions in health, clean & green energy
Application submissions for the EPIC Hackathon will be open from January 5th to February 5th, 2024
“Scientists need to embrace a problem solving mindset”
Dr Radha Rangarajan, Director, Central Drug Research Institute, Lucknow shares insights on the initiatives at the institute, industry academia interactions, technological trends, biopharma industry and much more
CSIR-CDRI collaborates with Bengaluru based startup to develop novel therapeutics for...
The collaboration will entail the use of advanced artificial intelligence and computational tools developed at Sravathi AI to design novel chemical entities (NCEs) with anti-cancer properties